Literature DB >> 11092259

Early down-regulation of cytochrome P450 3A and 2E1 in the regenerating rat liver is not related to the loss of liver mass or the process of cellular proliferation.

P Starkel1, S Laurent, M Petit, V Van Den Berge, L Lambotte, Y Horsmans.   

Abstract

AIMS/
BACKGROUND: Conflicting data have been reported concerning the modification of cytochrome P450 expression in the regenerating liver. Ligation of branches of the portal vein (PBL) perfusing 70% of the liver parenchyma, which produces regeneration and atrophy within the same liver, constitutes an ideal model to study the relative specificity of the early events in the regenerating liver and their relationship to the loss of liver mass.
METHODS: In this PBL model and in sham models, we studied the expression and the metabolic activities of two major cytochromes, CYP3A and CYP2E1, and the expression of inducible nitric oxide synthase protein (iNOS). They were simultaneously measured in the atrophying and regenerating liver lobes following PBL using Western Blot and HPLC methods.
RESULTS: The metabolic activities of both cytochromes were transiently and simultaneously down-regulated in the regenerating and atrophying lobes during the first 2-5 h after PBL. No significant modification was observed at the protein level. In contrast, iNOS protein was significantly induced in both lobes. Similar results were observed after sham operation.
CONCLUSIONS: The reduction of these CYP activities in both lobes after PBL and in sham livers suggests that other mechanisms than the regenerating process itself or the reduction of the liver mass might account for such down-regulation during the early phase of liver regeneration. The activation of nitric oxide (NO) and/or pro-inflammatory cytokine production provides clues to pathways liable to affect the CYP activities in the regenerating liver.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11092259     DOI: 10.1034/j.1600-0676.2000.020005405.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  3 in total

1.  Combinational effect of intestinal and hepatic CYP3A5 genotypes on tacrolimus pharmacokinetics in recipients of living donor liver transplantation.

Authors:  Eunhee Ji; Leena Choi; Kyung-Suk Suh; Joo-Youn Cho; Nayoung Han; Jung Mi Oh
Journal:  Transplantation       Date:  2012-10-27       Impact factor: 4.939

2.  Sho-saiko-to, a traditional herbal medicine, regulates gene expression and biological function by way of microRNAs in primary mouse hepatocytes.

Authors:  Kwang Hoon Song; Yun Hee Kim; Bu-Yeo Kim
Journal:  BMC Complement Altern Med       Date:  2014-01-11       Impact factor: 3.659

3.  Cytochrome P450 3A4FNx011B as pharmacogenomic predictor of tacrolimus pharmacokinetics and clinical outcome in the liver transplant recipients.

Authors:  Abdulkareem Albekairy; Abdulmalik Alkatheri; Shiro Fujita; Alan Hemming; Richard Howard; Alan Reed; Janet Karlix
Journal:  Saudi J Gastroenterol       Date:  2013 Mar-Apr       Impact factor: 2.485

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.